Search

Sean Mcgarry

Examiner (ID: 19573, Phone: (571)272-0761 , Office: P/1674 )

Most Active Art Unit
1635
Art Unit(s)
1635, 1809, 1805, 1674, 1621, 1624
Total Applications
1922
Issued Applications
1098
Pending Applications
296
Abandoned Applications
560

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 15883301 [patent_doc_number] => 10647983 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-05-12 [patent_title] => Reducing nonsense-mediated mRNA decay [patent_app_type] => utility [patent_app_number] => 14/916561 [patent_app_country] => US [patent_app_date] => 2014-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 21552 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14916561 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/916561
Reducing nonsense-mediated mRNA decay Sep 3, 2014 Issued
Array ( [id] => 10968268 [patent_doc_number] => 20140371301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-18 [patent_title] => 'TREATMENT OF TUMOR NECROSIS FACTOR RECEPTOR 2 (TNFR2) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO TNFR2' [patent_app_type] => utility [patent_app_number] => 14/477457 [patent_app_country] => US [patent_app_date] => 2014-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 25362 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14477457 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/477457
Treatment of tumor necrosis factor receptor 2 (TNFR2) related diseases by inhibition of natural antisense transcript to TNFR2 Sep 3, 2014 Issued
Array ( [id] => 15883301 [patent_doc_number] => 10647983 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-05-12 [patent_title] => Reducing nonsense-mediated mRNA decay [patent_app_type] => utility [patent_app_number] => 14/916561 [patent_app_country] => US [patent_app_date] => 2014-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 21552 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14916561 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/916561
Reducing nonsense-mediated mRNA decay Sep 3, 2014 Issued
Array ( [id] => 9910490 [patent_doc_number] => 20150065693 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-05 [patent_title] => 'COMPOSITION FOR PROPHYLAXIS OR TREATMENT OF VASCULAR OR CARDIAC VALVULAR CALCIFICATION COMPRISING DIPEPTIDYL PEPTIDASE-4 INHIBITOR' [patent_app_type] => utility [patent_app_number] => 14/473618 [patent_app_country] => US [patent_app_date] => 2014-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 5211 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14473618 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/473618
Composition for prophylaxis or treatment of vascular or cardiac valvular calcification comprising dipeptidyl peptidase-4 inhibitor Aug 28, 2014 Issued
Array ( [id] => 11364384 [patent_doc_number] => 20170002359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-05 [patent_title] => 'MODULATION OF PREKALLIKREIN (PKK) EXPRESSION' [patent_app_type] => utility [patent_app_number] => 14/915039 [patent_app_country] => US [patent_app_date] => 2014-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 76740 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14915039 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/915039
Modulation of prekallikrein (PKK) expression Aug 27, 2014 Issued
Array ( [id] => 13763963 [patent_doc_number] => 10174316 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-01-08 [patent_title] => Anti-connexin compounds targeted to connexins and methods of use thereof [patent_app_type] => utility [patent_app_number] => 14/467978 [patent_app_country] => US [patent_app_date] => 2014-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 17 [patent_no_of_words] => 34773 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14467978 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/467978
Anti-connexin compounds targeted to connexins and methods of use thereof Aug 24, 2014 Issued
Array ( [id] => 16892101 [patent_doc_number] => 11033628 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2021-06-15 [patent_title] => Targeting PAX2 for the treatment of breast cancer [patent_app_type] => utility [patent_app_number] => 14/464565 [patent_app_country] => US [patent_app_date] => 2014-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 59 [patent_no_of_words] => 27600 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14464565 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/464565
Targeting PAX2 for the treatment of breast cancer Aug 19, 2014 Issued
Array ( [id] => 9902133 [patent_doc_number] => 20150057334 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-26 [patent_title] => 'USE OF INHIBITORS OF ZDHHC2 ACTIVITY FOR MODULATION OF ADIPOGENESIS' [patent_app_type] => utility [patent_app_number] => 14/462510 [patent_app_country] => US [patent_app_date] => 2014-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6575 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14462510 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/462510
USE OF INHIBITORS OF ZDHHC2 ACTIVITY FOR MODULATION OF ADIPOGENESIS Aug 17, 2014 Abandoned
Array ( [id] => 9865412 [patent_doc_number] => 20150045431 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-12 [patent_title] => 'METHODS OF TREATING A CARDIOVASCULAR DISORDER IN A SUBJECT ON APO-C3 MODULATING THERAPY' [patent_app_type] => utility [patent_app_number] => 14/453167 [patent_app_country] => US [patent_app_date] => 2014-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16922 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14453167 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/453167
METHODS OF TREATING A CARDIOVASCULAR DISORDER IN A SUBJECT ON APO-C3 MODULATING THERAPY Aug 5, 2014 Abandoned
Array ( [id] => 10968262 [patent_doc_number] => 20140371295 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-18 [patent_title] => 'METHODS AND COMPOSITIONS TO PROTECT AQUATIC INVERTEBRATES FROM DISEASE' [patent_app_type] => utility [patent_app_number] => 14/338378 [patent_app_country] => US [patent_app_date] => 2014-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 42964 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14338378 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/338378
Methods and compositions to protect aquatic invertebrates from disease Jul 22, 2014 Issued
Array ( [id] => 10799464 [patent_doc_number] => 20160145617 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-26 [patent_title] => 'COMPOSITIONS FOR MODULATING TAU EXPRESSION' [patent_app_type] => utility [patent_app_number] => 14/906047 [patent_app_country] => US [patent_app_date] => 2014-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 62300 [patent_no_of_claims] => 78 [patent_no_of_ind_claims] => 47 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14906047 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/906047
Compositions for modulating Tau expression Jul 20, 2014 Issued
Array ( [id] => 10784507 [patent_doc_number] => 20160130663 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-12 [patent_title] => 'METHOD FOR PREDICTING RESPONSE TO CANCER TREATMENT' [patent_app_type] => utility [patent_app_number] => 14/904188 [patent_app_country] => US [patent_app_date] => 2014-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14297 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14904188 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/904188
METHOD FOR PREDICTING RESPONSE TO CANCER TREATMENT Jul 10, 2014 Abandoned
Array ( [id] => 10806824 [patent_doc_number] => 20160152982 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-02 [patent_title] => 'APTAMERS AGAINST GLIOMA CELLS' [patent_app_type] => utility [patent_app_number] => 14/903973 [patent_app_country] => US [patent_app_date] => 2014-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 6263 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14903973 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/903973
Aptamers against glioma cells Jul 8, 2014 Issued
Array ( [id] => 10947050 [patent_doc_number] => 20140350072 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-27 [patent_title] => 'NOVEL REPRESSOR ON IFN-LAMBDA PROMOTER AND SIRNA AGAINST ZEB1 AND BLIMP-1 TO INCREASE IFN-LAMBDA GENE ACTIVITY' [patent_app_type] => utility [patent_app_number] => 14/324717 [patent_app_country] => US [patent_app_date] => 2014-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 16318 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14324717 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/324717
Repressor on IFN-λ promoter and siRNA against ZEB1 and BLIMP-1 to increase IFN-λ gene activity Jul 6, 2014 Issued
Array ( [id] => 10947052 [patent_doc_number] => 20140350073 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-27 [patent_title] => 'DOUBLE-STRANDED NUCLEIC ACID MOLECULE, CANCER CELL PROLIFERATION INHIBITOR AND PHARMACEUTICAL AGENT SUITABLE FOR PREVENTION OR TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 14/324803 [patent_app_country] => US [patent_app_date] => 2014-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10288 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14324803 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/324803
Double-stranded nucleic acid molecule, cancer cell proliferation inhibitor and pharmaceutical agent suitable for prevention or treatment of cancer Jul 6, 2014 Issued
Array ( [id] => 9798968 [patent_doc_number] => 20150010912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-08 [patent_title] => 'METHODS OF DETECTING TUMOR CELLS' [patent_app_type] => utility [patent_app_number] => 14/323840 [patent_app_country] => US [patent_app_date] => 2014-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 26083 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14323840 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/323840
Methods of detecting tumor cells Jul 2, 2014 Issued
Array ( [id] => 10483633 [patent_doc_number] => 20150368652 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-24 [patent_title] => 'TREATMENT OF NEUROPATHIC PAIN' [patent_app_type] => utility [patent_app_number] => 14/312152 [patent_app_country] => US [patent_app_date] => 2014-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 28037 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14312152 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/312152
Treatment of neuropathic pain Jun 22, 2014 Issued
Array ( [id] => 10467049 [patent_doc_number] => 20150352064 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-10 [patent_title] => 'METHOD OF TREATING DELAYED HEALING OF A WOUND ASSOCIATED WITH DIABETES' [patent_app_type] => utility [patent_app_number] => 14/301301 [patent_app_country] => US [patent_app_date] => 2014-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11448 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14301301 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/301301
METHOD OF TREATING DELAYED HEALING OF A WOUND ASSOCIATED WITH DIABETES Jun 9, 2014 Abandoned
Array ( [id] => 10459872 [patent_doc_number] => 20150344887 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-03 [patent_title] => 'siRNA FOR INHIBITION OF USP15 EXPRESSION AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME' [patent_app_type] => utility [patent_app_number] => 14/300590 [patent_app_country] => US [patent_app_date] => 2014-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4286 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14300590 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/300590
siRNA FOR INHIBITION OF USP15 EXPRESSION AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME Jun 9, 2014 Abandoned
Array ( [id] => 10774650 [patent_doc_number] => 20160120805 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-05 [patent_title] => 'EXOSOMES FOR OROFACIAL DIAGNOSTICS AND THERAPEUTICS' [patent_app_type] => utility [patent_app_number] => 14/896017 [patent_app_country] => US [patent_app_date] => 2014-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 16499 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14896017 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/896017
EXOSOMES FOR OROFACIAL DIAGNOSTICS AND THERAPEUTICS Jun 4, 2014 Abandoned
Menu